-
Mashup Score: 13Marcel van den Brink shares path to City of Hope - 29 day(s) ago
Marcel van den Brink, MD, PhD, has joined City of Hope as president, overseeing the Los Angeles sites. Learn about his background in cancer care and research.
Source: www.cityofhope.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 15World Cancer Day: How City of Hope is closing the cancer care gap - 3 month(s) ago
World Cancer Day is on Feb. 4, 2024. City of Hope is recognizing the day by working to close the gap and reduce health disparities. Learn more.
Source: www.cityofhope.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 13City of Hope Honored Among ‘Top Hospitals and Health Systems’ for Diversity, Equity and Inclusion - 3 month(s) ago
DiversityInc has named City of Hope one of the US’ Top Hospitals and Health Systems for diversity, equity and inclusion. Learn how we made the top 10.
Source: www.cityofhope.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 69City of Hope scientists develop targeted chemotherapy able to kill all solid tumors in preclinical research - 9 month(s) ago
The City of Hope-developed investigational small molecule selectively disrupts DNA replication and repair in cancer cells, leaving healthy cells unaffected, a new study reports. CONTACT Zen Logsdon 626-409-9367zlogsdon@coh.org The City of Hope-developed small molecule AOH1996 targets a cancerous variant of the protein PCNA. In its mutated form, PCNA is critical in DNA replication and repair of all expanding tumors. Here we see untreated cancer cells (left) and cancer cells treated with AOH1996 (right) undergoing programmed cell death (violet). (Photo credit: City of Hope)LOS ANGELES — Researchers at City of Hope, one of the largest cancer research and treatment organizations in the United States, today published a new study explaining how they took a protein once thought to be too challenging for targeted therapy, proliferating cell nuclear antigen (PCNA), and developed a targeted chemotherapy that appears to annihilate all solid tumors in preclinical research. As the scientists conti
Source: www.cityofhope.orgCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 0Cancer Center Announces First Patient Has Received City of Hope’s Novel, Potentially Cancer-Stopping Pill - 9 month(s) ago
CONTACT Zen Logsdon 626-409-9367 zlogsdon@coh.org The Phase 1 clinical trial tests the safety of providing City of Hope-developed AOH1996 to people with reoccurring solid tumors. LOS ANGELES — City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced that the first patient to receive its novel, promising cancer medicine AOH1996 is doing well. The Phase 1 clinical trial testing the safety of a potentially cancer-stopping therapeutic developed by City of Hope in people with reoccurring solid tumors is expected to continue for the next two years. The investigational pill has been effective in preclinical research treating cells derived from breast, prostate, brain, ovarian, cervical, skin and lung cancers. Linda Malkas, Ph.D., professor in City of Hope’s Department of Molecular Diagnostics & Experimental Therapeutics, has been working on the research and subsequent discovery and development of AOH1996 for 20 years. AOH1996 is named
Source: www.cityofhope.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0World Cancer Day: Your Cancer Care, Your Community - 2 year(s) ago
World Cancer Day: Your Cancer Care, Your Community
Source: www.cityofhope.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
City of Hope physicians saw declines in cancer screenings and scrambled to address them.
Source: www.cityofhope.orgCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 2City of Hope opens oncolytic virus clinical trial for patients with advanced breast cancer - 3 year(s) ago
Read more about the first in the world trial offering a City of Hope-developed investigational therapy to humans with the hope of one day improving survival for patients with triple-negative breast cancer.
Source: www.cityofhope.orgCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 0By the Slimmest of Margins - 3 year(s) ago
Jim Belardi and his wife Leslie are making a transformative gift, representing the largest single contribution for blood cancer research, to support City of Hope’s Hematologic Malignancies Research Institute (HMRI.) The gift will accelerate progress on promising new therapies for some of the most difficult-to-treat blood cancers — cancers like the one Belardi survived.
Source: www.cityofhope.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 4Why Diversity in Clinical Trials Is Essential - 3 year(s) ago
City of Hope scientists seek to eliminate health inequities and increase participation in clinical studies by diverse populations.
Source: www.cityofhope.orgCategories: Hem/Oncs, Latest HeadlinesTweet
Marcel van den Brink Shares Path to Cancer Research Passion https://t.co/7fMmpFWM8S